(2S)-2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-phenylpropanamide
Structure Info
- Chemspace ID
- CSSB00159240501 (In-Stock Building Blocks)
- IUPAC Name
- (2S)-2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-phenylpropanamide
- Mol formula
- C24H28N4O2
- Mol weight
- 405 Da
- Catalog Number(s)
- A729320, AA01EP8N, AG01EPBF, AX65411, CP175115, CSC159240501, ST01EQS7, T30103, TX01EQH3
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.89
- Heavy atoms count
- 30
- Rotatable bond count
- 7
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.375
- Polar surface area (Å)
- 90
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 2
![Chemical structure of (2S)-2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-phenylpropanamide (C24H28N4O2) - CSSB00159240501](/st/structure/200/ad9aabeee8f9a6e1310819145bd833e1/NC%2528%253DO%2529%255BC%2540H%255D%2528CC1%253DCC%253DCC%253DC1%2529NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12.png "C24H28N4O2")
- Zoom the structure
- CSSB00159240501
Items Overall 15 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 3 days | United States To: | 98 | 1 mg | 95.70 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 5 mg | 369.60 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 50 mg | 2,107.60 | |
Description: APP-CHMINACA; CAS: 1185887-14-2 | ||||||
| Angene US | 10 days | United States To: | 98 | 1 mg | 116.10 | |
| Angene US | 10 days | United States To: | 98 | 5 mg | 449.10 | |
| Angene US | 10 days | United States To: | 98 | 50 mg | 2,565.00 | |
Description: App-chminaca; CAS: 1185887-14-2 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 1 mg | 103.50 | |
| A2B Chem | 12 days | United States To: | 98 | 5 mg | 401.35 | |
| A2B Chem | 12 days | United States To: | 98 | 50 mg | 2,294.25 | |
Description: APP-CHMINACA; CAS: 1185887-14-2 | ||||||
| AA BLOCKS | 12 days | United States To: | 98 | 1 mg | 110.00 | |
| AA BLOCKS | 12 days | United States To: | 98 | 5 mg | 426.80 | |
| AA BLOCKS | 12 days | United States To: | 98 | 50 mg | 2,438.70 | |
Description: APP-CHMINACA; CAS: 1185887-14-2 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 1 mg | 80.30 | |
| 10X CHEM | TBD | United States To: | 98 | 5 mg | 310.20 | |
| 10X CHEM | TBD | United States To: | 98 | 50 mg | 1,772.10 | |
Description: APP-CHMINACA; CAS: 1185887-14-2 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of (2S)-2-{[1-(5-fluoropentyl)-1H-indazol-3-yl]formamido}-3-phenylpropanamide - CSSB02515455772](/st/structure/200/0ec9b1524661f475a3beba8edb26f671/NC%2528%253DO%2529%255BC%2540H%255D%2528CC1%253DCC%253DCC%253DC1%2529NC%2528%253DO%2529C1%253DNN%2528CCCCCF%2529C2%253DCC%253DCC%253DC12.png)
![Chemical structure of (2S)-2-[(1-butyl-1H-indazol-3-yl)formamido]-3-phenylpropanamide - CSSB02515437823](/st/structure/200/e1c0e5eb123935c8ab4a9061776ca1f5/CCCCN1N%253DC%2528C%2528%253DO%2529N%255BC%2540%2540H%255D%2528CC2%253DCC%253DCC%253DC2%2529C%2528N%2529%253DO%2529C2%253DCC%253DCC%253DC12.png)
![Chemical structure of (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-phenylpropanamide - CSSB00102519596](/st/structure/200/d0727b9ddedf7295520f8d4d207601c4/NC%2528%253DO%2529%255BC%2540H%255D%2528CC1%253DCC%253DCC%253DC1%2529NC%2528%253DO%2529C1%253DNN%2528CC2%253DCC%253DC%2528F%2529C%253DC2%2529C2%253DCC%253DCC%253DC12.png)
![Chemical structure of 3-carbamoyl-3-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-2-methylpropanoic acid - CSSB00159239438](/st/structure/200/deb07801773bc576f9c2e0c5767c2d31/CC%2528C%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO%2529C%2528O%2529%253DO.png)
![Chemical structure of 3-carbamoyl-3-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-2,2-dimethylpropanoic acid - CSSB00159247553](/st/structure/200/8be19273c3ddd1c4e0e5b499bbd079d1/CC%2528C%2529%2528C%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO%2529C%2528O%2529%253DO.png)
![Chemical structure of 2-[(1-benzyl-1H-indazol-3-yl)formamido]-3,3-dimethylbutanamide - CSSB06629244450](/st/structure/200/894394cd04e6d1e048c11810a78bfdcc/CC%2528C%2529%2528C%2529C%2528NC%2528%253DO%2529c1nn%2528Cc2ccccc2%2529c2ccccc12%2529C%2528N%2529%253DO.png)
![Chemical structure of (2S)-2-({1-[(3-hydroxycyclohexyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanamide - CSSB00159239434](/st/structure/200/5ee65a9398bfb3fd533426fc79cd112e/CC%2528C%2529%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCC%2528O%2529C2%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO.png)
